323 related articles for article (PubMed ID: 22494592)
1. Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up.
Bantema-Joppe EJ; Schilstra C; de Bock GH; Dolsma WV; Busz DM; Langendijk JA; Maduro JH
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e471-7. PubMed ID: 22494592
[TBL] [Abstract][Full Text] [Related]
2. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
Vicini FA; Chen P; Wallace M; Mitchell C; Hasan Y; Grills I; Kestin L; Schell S; Goldstein NS; Kunzman J; Gilbert S; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1124-30. PubMed ID: 17967306
[TBL] [Abstract][Full Text] [Related]
3. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
Chen PY; Wallace M; Mitchell C; Grills I; Kestin L; Fowler A; Martinez A; Vicini F
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):991-7. PubMed ID: 19515514
[TBL] [Abstract][Full Text] [Related]
4. The effect of dose-volume parameters and interfraction interval on cosmetic outcome and toxicity after 3-dimensional conformal accelerated partial breast irradiation.
Leonard KL; Hepel JT; Hiatt JR; Dipetrillo TA; Price LL; Wazer DE
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):623-9. PubMed ID: 22867895
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional conformal hypofractionated simultaneous integrated boost in breast conserving therapy: results on local control and survival.
Bantema-Joppe EJ; van der Laan HP; de Bock GH; Wijsman R; Dolsma WV; Busz DM; Langendijk JA; Maduro JH
Radiother Oncol; 2011 Aug; 100(2):215-20. PubMed ID: 21640422
[TBL] [Abstract][Full Text] [Related]
6. Ductal carcinoma in situ--the influence of the radiotherapy boost on local control.
Wong P; Lambert C; Agnihotram RV; David M; Duclos M; Freeman CR
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e153-8. PubMed ID: 21664063
[TBL] [Abstract][Full Text] [Related]
7. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation.
Hepel JT; Tokita M; MacAusland SG; Evans SB; Hiatt JR; Price LL; DiPetrillo T; Wazer DE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1290-6. PubMed ID: 19395195
[TBL] [Abstract][Full Text] [Related]
9. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy.
Ciervide R; Dhage S; Guth A; Shapiro RL; Axelrod DM; Roses DF; Formenti SC
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e159-64. PubMed ID: 22579378
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy.
Vicini FA; Keisch M; Shah C; Goyal S; Khan AJ; Beitsch PD; Lyden M; Haffty BG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):512-8. PubMed ID: 22079730
[TBL] [Abstract][Full Text] [Related]
11. A cosmetic evaluation of breast cancer treatment: a randomized study of radiotherapy boost technique.
Vass S; Bairati I
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1274-82. PubMed ID: 16029782
[TBL] [Abstract][Full Text] [Related]
12. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant breast radiotherapy using a simultaneous integrated boost: clinical and dosimetric perspectives.
Alford SL; Prassas GN; Vogelesang CR; Leggett HJ; Hamilton CS
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):222-9. PubMed ID: 23551785
[TBL] [Abstract][Full Text] [Related]
14. Five year outcomes of hypofractionated simultaneous integrated boost irradiation in breast conserving therapy; patterns of recurrence.
Bantema-Joppe EJ; Vredeveld EJ; de Bock GH; Busz DM; Woltman-van Iersel M; Dolsma WV; van der Laan HP; Langendijk JA; Maduro JH
Radiother Oncol; 2013 Aug; 108(2):269-72. PubMed ID: 24055289
[TBL] [Abstract][Full Text] [Related]
15. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
[TBL] [Abstract][Full Text] [Related]
16. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
[TBL] [Abstract][Full Text] [Related]
17. Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost.
McDonald MW; Godette KD; Whitaker DJ; Davis LW; Johnstone PA
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):523-30. PubMed ID: 19775834
[TBL] [Abstract][Full Text] [Related]
18. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
19. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
